Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

Blood

Volumn 128, Issue 16, 2016, Pages 2083-2088

  Kakihana, Kazuhiko ^a   Fujioka, Yuki ^b,c   Suda, Wataru ^d   Najima, Yuho ^a   Kuwata, Go ^a   Sasajima, Satoshi ^f   Mimura, Iyo ^g   Morita, Hidetoshi ^g   Sugiyama, Daisuke ^b   Nishikawa, Hiroyoshi ^b   Hattori, Masahira ^d,h   Hino, Yutaro ^a   Ikegawa, Shuntaro ^a   Yamamoto, Keita ^a   Toya, Takashi ⁱ   Doki, Noriko ^a   Koizumi, Koichi ^a   Honda, Kenya ^e,f,j   Ohashi, Kazuteru ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f RIKEN Center for Integrative Medical Sciences   (Japan)

^g OKAYAMA UNIVERSITY   (Japan)

^h WASEDA UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; FENTANYL; LOPERAMIDE; METHYLPREDNISOLONE; OCTREOTIDE;

ABDOMINAL PAIN; ACUTE GRAFT VERSUS HOST DISEASE; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANEMIA; CASE REPORT; CHOLESTASIS; DELIRIUM; DIARRHEA; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOKALEMIA; HYPOTHYROIDISM; HYPOXIA; LIVER INJURY; MALE; MIDDLE AGED; NAUSEA; PAROXYSMAL ATRIAL FIBRILLATION; PILOT STUDY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SORE THROAT; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; ACUTE DISEASE; ALLOGRAFT; CLINICAL TRIAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INTESTINAL DISEASES; INTESTINE FLORA; LEUKEMIA, MYELOID, ACUTE; MICROBIOLOGY; PATHOLOGY;

ACUTE DISEASE; ADULT; ALLOGRAFTS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; GASTROINTESTINAL MICROBIOME; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INTESTINAL DISEASES; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PILOT PROJECTS; T-LYMPHOCYTES, REGULATORY;

EID: 84992074418     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-05-717652     Document Type: Review

References (20)

1. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007; 109(10):4119-4126.
2. Atarashi K, Tanoue T, Oshima K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013; 500(7461):232-236.
3. Arpaia N, Campbell C, Fan X., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504(7480):451-455.
4. Jenq RR, Taur Y, Devlin S.M., et al. Intestinal blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant. 2015; 21(8):1373-1383.
5. Biagi E, Zama D, Nastasi C., et al. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant. 2015; 50(7):992-998.
6. Taur Y, Jenq RR, Perales M.A., et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014; 124(7):1174-1182.
7. Holler E, Butzhammer P, Schmid K., et al. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014; 20(5):640-645.
8. Jenq RR, Ubeda C, Taur Y., et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012; 209(5):903-911.
9. Eriguchi Y, Takashima S, Oka H., et al. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood. 2012; 120(1):223-231.
10. Weber D, Oefner PJ, Hiergeist A, et al Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood. 2015; 126(14):1723-1728.
11. Ho VT, Cutler C, Carter S., et al. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005; 11(8):571-575.
12. de Castro CG Jr, Ganc AJ, Ganc R.L., Petrolli MS, Hamerschlack N. Fecal microbiota transplant after hematopoietic SCT: report of a successful case. Bone Marrow Transplant. 2015; 50(1):145.
13. Di Bella S., Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J Infect Chemother. 2015; 21(4):230-237.
14. Sokol H, Pigneur B, Watterlot L., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008; 105(43): 16731-16736.
15. Shahinas D, Silverman M, Sittler T., et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing. MBio. 2012; 3(5):e00338-12.
16. Shono Y, Docampo MD, Smith O.M., et al. Treatment with antibiotics containing activity against obligate anaerobes worsens GVHD survival in mice and humans after allogeneic BMT. Biol Blood Marrow Transplant. 2015; 21(2): S27-S28.
17. + regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant. 2010; 16(7):907-914.
18. Miura Y, Thoburn CJ, Bright E.C., et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood. 2004; 104(7): 2187-2193.
19. + regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci USA. 2013; 110(44): 17945-17950.
20. + T cells expressing the FoxP3 transcription factor. Immunity. 2009; 30(6): 899-911.